Stock INBS INTELLIGENT BIO SOLUTIONS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Intelligent Bio Solutions Inc.

Equities

INBS

US36151G6008

Real-time Estimate Cboe BZX
Other stock markets
 11:59:43 2024-07-03 am EDT 		5-day change 1st Jan Change
1.835 USD -0.27% Intraday chart for Intelligent Bio Solutions Inc. +1.94% -54.62%
Jun. 18 Intelligent Bio Solutions Inc. Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology CI
Jun. 12 Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic Study Part of 510(k) Pathway for Approval and Commences Review of Results
AQ
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
AQ
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
AQ
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
AQ
Kaival Brands Innovations Group (NASDAQ: KAVL) Secures $6M in Public Offering, Stock Surges Watch VTAK, OCGN, DYAI, INBS
AQ
Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector
AQ
INTELLIGENT BIO SOLUTIONS BEGINS SUBJECT DOSING AND SAMPLING FOR FDA 510(K) PHARMACOKINETIC STUDY FOR ITS INTELLIGENT FINGERPRINTING DRUG SCREENING TECHNOLOGY
AQ
Catheter Precision (NYSE American: VTAK) Announces New LockeT Purchase Order and Expands Sales Team Amid Surge in Trading Volume
AQ
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
AQ
Intelligent Bio Solutions Inc. Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
CI
Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
AQ
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
AQ
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
CI
Intelligent Bio Solutions Inc. Announces Board Changes
CI
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
AQ
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
AQ
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
AQ
Intelligent Bio Solutions Starts Subject Screening for Drug Testing System Study
MT
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
AQ
Intelligent Bio Solutions Inc. Completes Recruitment and Begins Subject Screening for FDA 510(K) Pharmacokinetic Study
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INBS Stock
  4. News Intelligent Bio Solutions Inc.